Stroke and brain atrophy in chronic chagas disease patients: A new theory proposition

Dementia e Neuropsychologia

Volumn 3, Issue 1, 2009, Pages 22-26

  Oliveira Filho, Jamary ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

American trypanosomiasis; Cerebrovascular disorders; Chagas disease; Cognition; Pathogenesis

Indexed keywords

EID: 68349156071     PISSN: 19805764     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1980-57642009DN30100005     Document Type: Review

References (35)

1. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1991;811:1-95.
2. Anez N, Crisante G, Rojas A. Update on Chagas disease in Venezuela: a review. Mem Inst Oswaldo Cruz 2004;99:781-787.
3. Aras R, Gomes I, Veiga M, Melo A. Vectorial transmission of Chagas' disease in Mulungu do Morro, Northeastern of Brazil. Rev Soc Bras Med Trop 2003;36:359-363.
4. Aras R, Veiga M, Gomes I, et al. Prevalence of Chagas' disease in Mulungu do Morro northeastern Brazil. Arq Bras Cardiol 2002;78:441-443.
5. Oliveira-Filho J, Viana LC, Vieira-de-Melo RM, et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a chagas disease cohort. Stroke 2005;36:2015-2017.
6. Navin TR, Roberto RR, Juranek DD, et al. Human and sylvatic Trypanosoma cruzi infection in California. Am J Public Health 1985;75:366-369.
7. Frank M, Hegenscheid B, Janitschke K, Weinke T. Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 1997;25:355-358.
8. Reesink HW. European strategies against the parasite transfusion risk. Transfus Clin Biol 2005;12:1-4.
9. Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis 2008;12:587-592.
10. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007;101:31-50.
11. Chagas C. Nova entidade mórbida do homem. Rezumo geral de estudos etiolojicos e clinicos. Mem Inst Oswaldo Cruz 1911;3:219-275.
12. Pittella JE, Meneguette C, Barbosa AJ. Histopathological and immunohistochemical study of the brain and heart in the chronic cardiac form of Chagas' disease. Arq Neuropsiquiatr 1993;51:8-15.
13. de Queiroz AC, Ramos EA. [Anatomo-pathological study of the brain in idiopathic cardiomegaly]. Arq Neuropsiquiatr 1979;37:405-411.
14. Pitella JE. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 1984;42:105-115.
15. de Queiroz AC. Estudo anatomopatológico do encéfalo na forma crônica da doença de Chagas. Rev Pat Trop 1978;7:135-145.
16. Alencar A. Atrofia cerebral cortical na cardiopatia crônica Chagásica. O Hospital 1964;66:807-815.
17. Alencar A. Atrofia do cérebro e anóxia na cardiopatia crônica da doença de Chagas. An Acad Bras Cien 1964;36:193-197.
18. Alencar A. Alterações cerebelares em pacientes com cardiopatia crônica Chagásica. Arq Neuropsiquiatr 1967;25:191-198.
19. Andrade Z, Sadigursky, M. Tromboembolismo em chagásicos sem insuficência cardíaca. Gazeta Medica 1971:59-64.
20. Samuel J, Oliveira M, Correa De Araujo RR, Navarro MA, Muccillo G. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983;52:147-151.
21. Rocha HP, Andrade ZA. Pulmonary thrombo-embolic phenomena in subjects of chronic Chagas' myocarditis. Arq Bras Med 1955;45:355-364.
22. Nunes MC, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas' cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J Am Soc Echocardiogr 2005;18:761-767.
23. Jesus PAP, Vieira-de-Melo RM, Lacerda AM, et al. Chagas disease and microembolic signals on transcranial doppler are predictors of death in patients with congestive heart failure. Neurology 2007;68(suppl):394.
24. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965-970.
25. Carod-Artal FJ, Vargas AP, Melo M, Horan TA. American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke. J Neurol Neurosurg Psychiatry 2003;74:516-518.
26. Oliveira-Filho J, Camargo ECS, Oliveira LMB, et al. Genomic response profile in cardiomyopathy and stroke associated with Chagas disease: A microarray analysis study. Cerebrovasc Dis 2008;25(suppl. 2):107.
27. Oliveira-Filho J, Vieira-de-Melo RM, Reis PSO, et al. Chagas disease is independently associated with brain atrophy. J Neurol (in press).
28. Jefferson AL, Massaro JM, Wolf PA, et al. Inflammatory bio-markers are associated with total brain volume: the Framing-ham Heart Study. Neurology 2007;68:1032-1038.
29. Abel LC, Rizzo LV, Ianni B, et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 2001;17:99-107.
30. Cunha-Neto E, Rizzo LV, Albuquerque F, et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1998;31:133-137.
31. Ferreira RC, Ianni BM, Abel LC, et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003;98:407-411.
32. Mangone CA, Sica RE, Pereyra S, et al. Cognitive impairment in human chronic Chagas' disease. Arq Neuropsiquiatr 1994;52:200-203.
33. Wackermann PV, Fernandes RM, Elias J, Jr., Dos Santos AC, Marques W, Jr., Barreira AA. Involvement of the central nervous system in the chronic form of Chagas' disease. J Neurol Sci 2008;269:152-157.
34. Dias JS, Lacerda AM, Vieira-de-Melo RM, et al. Cognitive dys-function in chronic Chagas disease cardiomyopathy. Dement Neuropsychol 2009;3:27-33.
35. Costa GC, Rocha MO, Moreira PR, et al. Functional IL-10 Gene Polymorphism Is Associated with Chagas Disease Cardiomyopathy. J Infect Dis 2009;199:451-454.